Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $888.5 million versus the consensus estimate of $867.09 million.

GUIDANCE:

Edwards Lifesciences sees Q1 2018 EPS of $1.04-$1.14. Edwards Lifesciences sees Q1 2018 revenue of $3.5-3.9 billion.

Edwards Lifesciences sees FY2018 EPS of $4.43-$4.63. Edwards Lifesciences sees FY2018 revenue of $900-950 million.

For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.

Earnings Guidance Hot Earnings

Edwards Lifesciences (EW) PT Raised to $150 at BMO CapitalFebruary 2, 2018 8:21 AM Edwards Lifesciences (EW) PT Raised to $174 at Canaccord GenuityFebruary 2, 2018 7:08 AM Edwards Lifesciences (EW) PT Raised to $138 at Morgan StanleyFebruary 2, 2018 6:55 AM Edwards Lifesciences (EW) PT Raised to $155 at BarclaysFebruary 2, 2018 4:34 AM Edwards Lifesciences (EW) PT Raised to $140 at JMP SecuritiesFebruary 2, 2018 4:16 AM Edwards Lifesciences Reports Fourth Quarter ResultsFebruary 1, 2018 4:15 PM